You are here: Home » Companies » News
Business Standard

Transgene Biotek to delist from Indian stock exchanges

Apart from Bombay Stock Exchange, the company is also listed on Luxembourg Stock Exchange

Press Trust of India  |  New Delhi 

Biotechnology firm today said that its board of directors has decided to its shares from

"The board of directors of the company at its meeting held on September 3, 2012, inter alia, has decided to the equity shares of the company from the all the recognised Indian Stock Exchanges," said in a filing to BSE.

Apart from Bombay Stock Exchange, the company is also listed on Luxembourg Stock Exchange.

said its proposal to is subject to approval of shareholders of the company and statutory approvals.


The company, however, did not assign any reason for the delisting.

Shares of were today trading at Rs 11.25 per scrip in the afternoon trade on BSE, up 4.85% from its previous close.

 Founded in 1991 by Koteswara Rao, the Hyderabad-based company is among the first biotechnology in India.

It has products in the therapeutic areas of cancer, auto immunity and other bio-generics apart from drug delivery devices for ailments such as diabetes and HIV infection.

RECOMMENDED FOR YOU